Northern Trust
VCNX

Northern Trust’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Northern Trust’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-111
Closed -$8.32K – 4533
2023
Q2 		$8.32K Hold
111
– – ﹤0.01% 4489
2023
Q1 		$9.34K Hold
111
– – ﹤0.01% 4528
2022
Q4 		$15.1K Hold
111
– – ﹤0.01% 4531
2022
Q3 		$12K Buy
111
+29
+35% +$5.69K ﹤0.01% 4626
2022
Q2 		$19K Buy
82
+2
+3% +$511 ﹤0.01% 4636
2022
Q1 		$22K Hold
80
– – ﹤0.01% 4665
2021
Q4 		$17K Hold
80
– – ﹤0.01% 4720
2021
Q3 		$36K Hold
80
– – ﹤0.01% 4575
2021
Q2 		$47K Hold
80
– – ﹤0.01% 4503
2021
Q1 		$50K Buy
80
+1
+1% +$643 ﹤0.01% 4382
2020
Q4 		$34K Buy
79
+13
+20% +$5.44K ﹤0.01% 4272
2020
Q3 		$25K Buy
66
+15
+29% +$16.4K ﹤0.01% 4187
2020
Q2 		$39K Sell
51
-3
-6% -$2.34K ﹤0.01% 4089
2020
Q1 		$45K Hold
54
– – ﹤0.01% 3968
2019
Q4 		$55K Hold
54
– – ﹤0.01% 4043
2019
Q3 		$81K Hold
54
– – ﹤0.01% 3959
2019
Q2 		$62K Hold
54
– – ﹤0.01% 4046
2019
Q1 		$59K Hold
54
– – ﹤0.01% 4020
2018
Q4 		$41K Sell
54
-7
-11% -$8.55K ﹤0.01% 4083
2018
Q3 		$93K Buy
+61
New +$126K ﹤0.01% 4045

Other funds holding VCNX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TC
Tacita Capital Toronto, Ontario, Canada $184M AUM 26.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Northern Trust's VCNX Position: Q3 2023 in Review

Northern Trust sold out of Vaccinex, Inc. Common Stock (VCNX) in Q3 2023, closing a stake of 111 shares — an estimated $8.32K sold.

Northern Trust first reported a position in VCNX in Q3 2018 and held it in 20 quarters. The position peaked at $93K in Q3 2018. 18 funds tracked by Wall St. Rank hold VCNX as of Q3 2023.

  • Northern Trust reported no remaining Vaccinex, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Northern Trust sold 111 Vaccinex, Inc. Common Stock shares in Q3 2023, an estimated $8.32K.
  • Northern Trust first reported a position in Vaccinex, Inc. Common Stock in Q3 2018 and held it in 20 quarters.
  • Northern Trust's Vaccinex, Inc. Common Stock position peaked at $93K in Q3 2018.
  • 18 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q3 2023.

Based on Northern Trust's 13F filing for Q3 2023, filed 13 Nov 2023.